ROI-17-0490 Vaxxit: Vaxxit Tat Vaccine - 2 assets

1 US patent plus 2 international counterparts relating to TatimmuneTM (scientific name: Tat vaccine), a proprietary new treatment for HIV/AIDS.

A broker EOU is available upon request.

Grantback license required.

Package data provided by Richardson Oliver Insights.

Contact Info: John Green, +44 (0)207 887 6382


Send message

Please register to send messages.